Published by Josh White on 22nd May 2026
(Sharecast News) - RUA Life Sciences said in an update on Friday that it expected to report a smaller EBITDA loss, broadly reaching breakeven on an adjusted basis, after revenue growth in its UK contract development and manufacturing and biomaterials businesses offset weaker trading at Abiss.
URL: http://www.digitallook.com/dl/news/story/35952808/...